The Growing Clinical Signal The shift began with animal studies over a decade ago, led by researchers such as Elisabet Jerlhag Holm, who found that GLP-1 agonists dampened addictive behaviors in rodents hooked on alcohol, nicotine, cocaine, and opioids
Bottom Line The playbook for retirement investing involves early offense that shifts into strong defense
N Engl J Med 370(15):13831392 Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bhm M, Brunner-La Rocca H-P, Choi D-J, Chopra V, Chuquiure-Valenzuela E et al (2021) Empagliflozin in heart failure with a preserved ejection fraction
According to the data provided by the Synapse Database, As of July 16, 2024, there are 399 investigational drugs for the GLP-1 target, including 102 indications, 324 R&D institutions involved, with related clinical trials reaching 2606, and as many as 10113 patents
Understanding the nature of these reactions helps patients distinguish between expected, self-limiting effects and symptoms that may warrant medical review
De hecho, ni siquiera es necesario que ests atento a los duendes